|
Re: LINK for the AGM
|
3
|
Resverlogix Corp.
|
Jun 21, 2022 04:14PM
|
|
Re: Level 2 Quotes this morning
|
2
|
Resverlogix Corp.
|
Jun 16, 2022 10:11PM
|
|
Re: Level 2 Quotes this morning
|
1
|
Resverlogix Corp.
|
Jun 16, 2022 05:12PM
|
|
Re: Level 2 Quotes this morning
|
1
|
Resverlogix Corp.
|
Jun 16, 2022 02:29PM
|
|
Re: Another article. Mechanism related.
|
3
|
Resverlogix Corp.
|
Jun 13, 2022 09:06PM
|
|
Re: Hepalink
|
2
|
Resverlogix Corp.
|
Jun 13, 2022 01:18PM
|
|
Re: New insights from this study -- Questions for scientists.
|
4
|
Resverlogix Corp.
|
Jun 09, 2022 11:38AM
|
|
Re: New insights from this study -- Questions for scientists.
|
2
|
Resverlogix Corp.
|
Jun 08, 2022 03:05PM
|
|
Re: Apropos AGM
|
4
|
Resverlogix Corp.
|
Jun 08, 2022 02:58PM
|
|
Re: Concerns Mount Over COVID-19 'Rebounds' After Treatment With Pfizer's Paxlovid
|
8
|
Resverlogix Corp.
|
Jun 02, 2022 01:26PM
|
|
Re: Article
|
5
|
Resverlogix Corp.
|
May 29, 2022 07:23PM
|
|
Re: AGM attendance
|
8
|
Resverlogix Corp.
|
May 24, 2022 04:30PM
|
|
Re: Covid PIII Questions and Thoughts
|
4
|
Resverlogix Corp.
|
May 23, 2022 04:58PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
9
|
Resverlogix Corp.
|
May 22, 2022 01:53PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
6
|
Resverlogix Corp.
|
May 22, 2022 01:44PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
5
|
Resverlogix Corp.
|
May 21, 2022 11:36PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
3
|
Resverlogix Corp.
|
May 20, 2022 05:24PM
|
|
Re: IR response
|
2
|
Resverlogix Corp.
|
May 07, 2022 01:38AM
|
|
Re: IR response
|
3
|
Resverlogix Corp.
|
May 06, 2022 09:14PM
|
|
Re: Pfizer sees strong demand for COVID pill as profits surge.
|
4
|
Resverlogix Corp.
|
May 05, 2022 12:30AM
|
